About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
- USD4.07
- USD4.13
- USD3.86
- USD10.97
- -23.90%
- --
- 44.47k
- 97.54k
- 160M
- 3.02
- -13.90%
Stock News
yesterday
: Virgin Orbit stock plunges after report says company will cease operations
MarketWatch
yesterday
: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged
MarketWatch
yesterday
NY grand jury indicts Trump in hush money payment case
CNBC
yesterday
Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results
MarketWatch
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
